JP2005515778A5 - - Google Patents

Download PDF

Info

Publication number
JP2005515778A5
JP2005515778A5 JP2003564211A JP2003564211A JP2005515778A5 JP 2005515778 A5 JP2005515778 A5 JP 2005515778A5 JP 2003564211 A JP2003564211 A JP 2003564211A JP 2003564211 A JP2003564211 A JP 2003564211A JP 2005515778 A5 JP2005515778 A5 JP 2005515778A5
Authority
JP
Japan
Prior art keywords
organism
tissue
nucleic acid
target nucleic
acid prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003564211A
Other languages
English (en)
Other versions
JP4515767B2 (ja
JP2005515778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/002844 external-priority patent/WO2003064615A2/en
Publication of JP2005515778A publication Critical patent/JP2005515778A/ja
Publication of JP2005515778A5 publication Critical patent/JP2005515778A5/ja
Application granted granted Critical
Publication of JP4515767B2 publication Critical patent/JP4515767B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (2)

  1. 生物体から得られた組織または身体排泄物もしくは液から調製された該標的核酸を含む試料を用いて該生物体における癌を診断するための請求項１８記載の方法。
  2. 生物体から得られた組織または身体排泄物もしくは液から調製された該標的核酸を含む試料を用いて該生物体における細胞老化を診断するための請求項１８記載の方法。
JP2003564211A 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅 Expired - Fee Related JP4515767B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35359102P 2002-01-31 2002-01-31
PCT/US2003/002844 WO2003064615A2 (en) 2002-01-31 2003-01-31 Amplifying repetitive nucleic acid sequences

Publications (3)

Publication Number Publication Date
JP2005515778A JP2005515778A (ja) 2005-06-02
JP2005515778A5 true JP2005515778A5 (ja) 2006-03-23
JP4515767B2 JP4515767B2 (ja) 2010-08-04

Family

ID=27663226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564211A Expired - Fee Related JP4515767B2 (ja) 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅

Country Status (10)

Country Link
US (2) US7695904B2 (ja)
EP (1) EP1476561B1 (ja)
JP (1) JP4515767B2 (ja)
CN (1) CN100473723C (ja)
AT (1) ATE534746T1 (ja)
AU (1) AU2003208902B2 (ja)
CA (1) CA2474468C (ja)
ES (1) ES2379375T3 (ja)
HK (1) HK1072275A1 (ja)
WO (1) WO2003064615A2 (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585974B1 (en) * 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
US8084443B2 (en) 2007-10-01 2011-12-27 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
CA2697373C (en) 2007-08-27 2019-05-21 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CN101230403B (zh) * 2008-02-21 2010-12-29 浙江理工大学 解析染色体端粒g-末端序列的方法
EP2342360B1 (en) 2008-10-17 2016-01-06 Geron Corporation Method for identification of sensitivity of a patient to telomerase inhibition therapy
CN107083444B (zh) 2008-12-22 2023-03-14 犹他大学研究基金会 单色多重定量pcr
US20110207128A1 (en) * 2010-02-16 2011-08-25 Cawthon Richard M Methods and kits for determining biological age and longevity based on gene expression profiles
JP2011223940A (ja) * 2010-04-21 2011-11-10 Asahi Breweries Ltd 偽陰性を排除するｐｃｒ検査方法およびそれに使用するプライマー
JP6273198B2 (ja) 2011-03-28 2018-01-31 ジェロン・コーポレーションＧｅｒｏｎ Ｃｏｒｐｏｒａｔｉｏｎ 定量的ｐｃｒによる、ホルマリン固定パラフィン包埋（ｆｆｐｅ）試料におけるテロメア長測定
JP5288387B1 (ja) * 2011-10-13 2013-09-11 学校法人東京女子医科大学 テロメア配列増幅用プライマー
WO2013101290A1 (en) * 2011-12-29 2013-07-04 Qiagen Methods of using telomeres as markers for aging
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US20130310269A1 (en) * 2012-05-04 2013-11-21 Austin So Hot-start digital pcr
US9200327B2 (en) 2012-11-30 2015-12-01 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
KR102174763B1 (ko) 2012-11-30 2020-11-06 제론 코포레이션 텔로머라제 억제자로 세포 증식성 질환 치료용 진단 마커
EP2971154A4 (en) * 2013-03-14 2017-03-01 Ibis Biosciences, Inc. Nucleic acid control panels
US10093970B2 (en) 2013-03-15 2018-10-09 New York University Method for single cell analysis of telomere length using pre-amplification and multiple-copy reference sequence
JP2016512696A (ja) * 2013-03-15 2016-05-09 アーノルド, ライル, ジェイ.ARNOLD, Lyle, J. アセンブラ配列を利用する断片化された標的核酸の増幅方法
CA2912216A1 (en) 2013-05-22 2014-11-27 Telomere Diagnostics, Inc. Measures of short telomere abundance
GB201418144D0 (en) * 2014-10-14 2014-11-26 Univ Cardiff High throughput sequencing
JP2018501799A (ja) * 2014-12-30 2018-01-25 テロメア ダイアグノスティクス インコーポレイテッド マルチプレックス定量的ｐｃｒ
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
US10577643B2 (en) * 2015-10-07 2020-03-03 Illumina, Inc. Off-target capture reduction in sequencing techniques
US10186789B1 (en) 2018-04-13 2019-01-22 Rustcraft Industries LLC Keyed cable and connector system
CN112029841B (zh) 2019-06-03 2024-02-09 香港中文大学 定量端粒长度和基因组基序的方法
CN113862339B (zh) * 2021-12-01 2022-03-22 广州滴纳生物科技有限公司 核酸组合产品、检测试剂盒和扩增靶核酸的方法
CN117230169B (zh) * 2023-11-13 2024-02-13 元码基因科技（北京）股份有限公司 用于长片段端粒序列测序的接头、预文库及其构建方法
CN117248003B (zh) * 2023-11-13 2024-04-12 元码基因科技（北京）股份有限公司 用于完整端粒扩增子测序的组合物、预文库及其构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020124A (en) 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5512441A (en) * 1994-11-15 1996-04-30 American Health Foundation Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method
US5741677A (en) 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
JP3718892B2 (ja) * 1996-02-05 2005-11-24 三菱化学株式会社 ヒト・テロメラーゼ活性の測定方法
JP4013333B2 (ja) 1998-06-05 2007-11-28 株式会社Ｂ＆Ｃラボラトリーズ 皮膚の老化度の測定方法および測定用キット
US6436677B1 (en) * 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription

Similar Documents

Publication Publication Date Title
JP2005515778A5 (ja)
JP2005523065A5 (ja)
DE602005016527D1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen körperflüssigkeiten
EP2667194A3 (en) Ratio based biomarkers and methods of use thereof
WO2005085860A3 (en) New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
PL1601450T3 (pl) Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej
WO2007039319A8 (en) Dna microarray for rapid identification of candida albicans in blood cultures
WO2002040634A3 (en) Expression miniarrays and uses thereof
EP1266608A3 (en) Biological fluid sampling and analyte measurement devices and methods
EP2186912A3 (en) Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
WO2006128042A3 (en) Methods of identifying mutations in nucleic acid
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
EP2535718A3 (en) Methods for early diagnosis of kidney disease
EP1722230A3 (en) Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
WO2006060393A3 (en) Biological systems analysis
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2002092858A3 (en) Methods of screening for disease
WO2004113574A3 (en) Methods for disease screening
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer